12:00 AM
 | 
Aug 10, 2015
 |  BC Week In Review  |  Company News  |  Deals

Aslan, ACT Genomics deal

Aslan and ACT partnered to research the genomic background of patients who displayed better than expected response rates in a clinical trial of ASLAN001, an oral...

Read the full 120 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >